Related Experiment Video
Updated: Aug 20, 2025
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.3K
Advanced nanomaterial for prostate cancer theranostics
Bin Hao1, Li Wei2, Yusheng Cheng1
1Department of Urology, Central Hospital, China Railway 17th Bureau Group Co., Ltd., Shanxi, China.
Frontiers in Bioengineering and Biotechnology
|November 17, 2022
Summary
Early prostate cancer (PC) detection and precise therapies are crucial due to late-stage diagnosis. This review covers diagnostic methods and advanced treatments, emphasizing integrated diagnosis and therapy with nanomaterials for future cancer control.
Area of Science:
- Oncology
- Biomedical Engineering
- Nanotechnology
Background:
- Prostate cancer (PC) is a leading cancer in men globally.
- Early-stage PC often lacks distinct symptoms, leading to delayed diagnosis and missed treatment opportunities.
- Effective, targeted, and minimally invasive treatments are essential for managing PC.
Purpose of the Study:
- To review current and emerging diagnostic methods for prostate cancer.
- To explore advanced therapeutic strategies for prostate cancer treatment.
- To highlight the role of nanomaterials in PC and the future of integrated diagnosis and therapy.
Main Methods:
- Review of literature on prostate cancer diagnosis and therapy.
- Analysis of prostate-specific biomarker detection techniques.
- Examination of molecular imaging modalities for PC.
- Summary of chemotherapy, gene therapy, and therapeutic nanomaterial applications.
- Assessment of nanomaterial development in PC treatment.
Main Results:
- Biomarker detection and molecular imaging offer improved PC diagnosis.
- Advanced therapies including chemotherapy, gene therapy, and nanomaterials show promise for PC treatment.
- Nanomaterials are pivotal in developing targeted and effective PC therapies.
Conclusions:
- Sensitive and precise early diagnosis is critical for effective prostate cancer management.
- Targeted and minimally invasive therapies are advancing PC treatment.
- The integration of diagnosis and therapy using nanomaterials represents a significant future direction for combating prostate cancer.
